JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

Strona główna・Stock List・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Closed

SectorHealthcare

493.93 -0.3

Buy Sell

Overview

Share price change

24h

Current

Min

485.7

Max

499.62

Key metrics
By Trading Economics
Income	-72M -114M
Sales	74M 287M
Profit margin	-39.75
Employees	528
EBITDA	-68M -106M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+39.12% upside

Dividends
By Dow Jones
Next Earnings	25 lut 2026

Market Stats
By TradingEconomics
Market Cap	2.1B 11B
Previous open	494.23
Previous close	493.93

News Sentiment

By Acuity

34%

66%

89 / 352 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

263.2 / 277.1 Support & Resistance

Madrigal Pharmaceuticals Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 sty 2026, 22:31 UTC

Earnings

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29 sty 2026, 22:05 UTC

Earnings

Stryker Logs Higher 4Q Profit On Sales Gains

29 sty 2026, 21:54 UTC

Earnings

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29 sty 2026, 21:36 UTC

Earnings

Visa 1Q Sales Climb on Strong Holiday Shopping

29 sty 2026, 23:57 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29 sty 2026, 23:56 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29 sty 2026, 23:53 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29 sty 2026, 23:51 UTC

Earnings

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29 sty 2026, 23:49 UTC

Market Talk

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29 sty 2026, 23:49 UTC

Market Talk

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29 sty 2026, 23:47 UTC

Market Talk

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29 sty 2026, 23:35 UTC

Earnings

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29 sty 2026, 23:32 UTC

Market Talk

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29 sty 2026, 23:32 UTC

Market Talk

Global Equities Roundup: Market Talk

29 sty 2026, 23:15 UTC

Market Talk

Earnings

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29 sty 2026, 22:27 UTC

Earnings

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 sty 2026, 22:27 UTC

Earnings

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29 sty 2026, 22:12 UTC

Earnings

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 sty 2026, 21:55 UTC

Earnings

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29 sty 2026, 21:50 UTC

Market Talk

Earnings

Financial Services Roundup: Market Talk

29 sty 2026, 21:50 UTC

Earnings

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29 sty 2026, 21:50 UTC

Market Talk

Earnings

Health Care Roundup: Market Talk

29 sty 2026, 21:50 UTC

Market Talk

Earnings

Auto & Transport Roundup: Market Talk

29 sty 2026, 21:49 UTC

Earnings

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29 sty 2026, 21:46 UTC

Earnings

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29 sty 2026, 21:36 UTC

Earnings

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29 sty 2026, 21:32 UTC

Earnings

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 sty 2026, 21:32 UTC

Earnings

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 sty 2026, 21:30 UTC

Earnings

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29 sty 2026, 21:30 UTC

Earnings

Apple 1Q Mac Rev $8.39B >AAPL

Peer Comparison

Price change

Madrigal Pharmaceuticals Inc Forecast

Price Target

By TipRanks

39.12% upside

12 Months Forecast

Average 690.8 USD 39.12%

High 964 USD

Low 533 USD

Based on 13 Wall Street analysts offering 12 month price targets forMadrigal Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

Buy

Hold

Sell

Based on 13 analysts giving stock ratings to Madrigal Pharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

263.2 / 277.1Support & Resistance

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Sentiment

By Acuity

89 / 352 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.